{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:39:28Z","timestamp":1786995568489,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MYG-151207"],"award-info":[{"award-number":["MYG-151207"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001515","name":"Cure Kids","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019168","name":"Starship Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019168","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Ottawa Research Chair"},{"DOI":"10.13039\/501100001804","name":"Canada Research Chair","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012856","name":"Alberta Children\u2019s Hospital Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012856","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010779","name":"Centre hospitalier universitaire Sainte-Justine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012854","name":"Children\u2019s Hospital Research Institute of Manitoba","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012854","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014730","name":"CHEO Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014730","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hospital for Sick Children Research Institute"},{"name":"Stollery Children\u2019s Hospital"},{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Western Ontario"},{"name":"Women and Children\u2019s Health Research Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bronchiolitis is a common lung infection that affects infants and young children. While most children can be treated at home, some require hospitalisation where supportive care, such as fluids and oxygen, is the suggested treatment. Bronchiolitis is the leading cause of infant hospitalisation in developed countries and exerts a significant burden on the healthcare system. The aim of the Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone (BIPED) study is to evaluate the effects of a combination of epinephrine and dexamethasone, given during initial presentation at the emergency department, on hospitalisation for bronchiolitis. This article outlines the statistical analysis plan (SAP) for the BIPED study.<\/jats:p>\n                    <jats:p>The BIPED study is a Phase III, multi-centre, randomised, controlled, double-blinded superiority, placebo-controlled trial to determine whether the combination of epinephrine and dexamethasone is successful in reducing hospitalisation for bronchiolitis up to 7 days following presentation at an emergency department with bronchiolitis. The secondary outcomes include hospital admissions for bronchiolitis at the emergency department enrolment visit, and all-cause hospital admissions, health care provider visits and health care-related costs in the 21\u00a0days following enrolment. The safety outcomes are gastrointestinal bleeding, serious bacterial infection, severe varicella and death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The BIPED study will provide evidence on whether a combination of epinephrine and dexamethasone reduces hospitalisation in infants following presentation to the emergency department with bronchiolitis. These data will be analyzed using this SAP, submitted before the data became available for analysis, to reduce the risk of bias in our reported outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT03567473. Registered on June 25, 2018.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09125-w","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:51:56Z","timestamp":1762959116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A randomised controlled trial comparing epinephrine and dexamethasone to placebo in the treatment of infants with bronchiolitis (BIPED study): a statistical analysis plan"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-4251","authenticated-orcid":false,"given":"Anna","family":"Heath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina I.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tremaine","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Wills-Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Offringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Pechlivanoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry P.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart R.","family":"Dalziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Plint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"KidsCan Pediatric Emergency Research Canada (PERC) Innovative Pediatric Clinical Trials and Pediatric Research in Emergency Department International Collaborative (PREDICT) BIPED Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Pullenayegum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Round","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Willan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Meckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Nigrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"15","key":"9125_CR1","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","volume":"282","author":"D Shay","year":"1999","unstructured":"Shay D, Holman R, Newman R, Liu L, Stout J, Anderson L. Bronchiolitis-associated hospitalizations among US children 1980\u20131996. JAMA. 1999;282(15):1440\u20136.","journal-title":"JAMA"},{"key":"9125_CR2","unstructured":"Njoo H, Pelletier L, Spika L. Infectious disease. In: Canadian Institute for Health Information, Canadian Lung Association, Health Canada, Statistics Canada, editors. Canadian Institute for Health Information, eds. Respiratory Disease in Canada, Toronto, Ontario, Canada: Canadian Institute for Health Information 2001:65\u201387."},{"issue":"11","key":"9125_CR3","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1086\/379740","volume":"188","author":"J Langley","year":"2003","unstructured":"Langley J, LeBlanc J, Smith B, Wang E. Increasing incident of hospitalization for bronchiolitis among Canadian children. J Infect Dis. 2003;188(11):1764\u20137.","journal-title":"J Infect Dis"},{"key":"9125_CR4","unstructured":"Craig E, Jackson C, Han D, NZCYES Steering Committee. Monitoring the Health of New Zealand Children and Young People: Indicator Handbook. New Zealand: Paediatric Society of New Zealand, New Zealand Child and Youth Epidemiology Service, Auckland; 2007."},{"issue":"10","key":"9125_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archpedi.157.10.957","volume":"157","author":"L Hartling","year":"2003","unstructured":"Hartling L, Wiebe N, Russell K, Patel H, Klassen T. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med. 2003;157(10):957\u201364.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"9125_CR6","unstructured":"\". I. f. H. a. C. E. (NICE), \"Bronchiolitis in children: diagnosis and management.,\" NICE, https:\/\/www.nice.org.uk\/Guidance\/NG9. June 1st 2015. Accessed 30 Mar 2016."},{"issue":"20","key":"9125_CR7","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1056\/NEJMoa0900544","volume":"360","author":"A Plint","year":"2009","unstructured":"Plint A, Johnson D, Patel H, Wiebe N, Correll R, Brant R, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009;360(20):2079\u201389.","journal-title":"N Engl J Med"},{"issue":"9","key":"9125_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/pch\/19.9.485","volume":"19","author":"J Friedman","year":"2014","unstructured":"Friedman J, Rieder M, Walton J. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014;19(9):485\u201398.","journal-title":"Paediatr Child Health"},{"key":"9125_CR9","doi-asserted-by":"crossref","unstructured":"Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.\u00a0Pediatr. 2014;134(5):e1474-502.","DOI":"10.1542\/peds.2014-2742"},{"key":"9125_CR10","doi-asserted-by":"publisher","unstructured":"Plint AC, Heath A, Rowe T, Vogel KI, Wills-Ibarra N, O'Brien S, Borland ML, Johnson DW, Zorc JJ, Pechlivanoglou P, Schuh S. A randomized controlled trial comparing epinephrine and dexamethasone to placebo in the treatment of infants with bronchiolitis: the Bronchiolitis in Infants Placebo versus Epinephrine and Dexamethasone (BIPED) study protocol. ERJ Open Research. in press 2025. https:\/\/doi.org\/10.1183\/23120541.01298-2024.","DOI":"10.1183\/23120541.01298-2024"},{"key":"9125_CR11","doi-asserted-by":"crossref","unstructured":"Bialy L, Plint A, Zemek R, Johnson D, Klassen T, Osmond M, Freedman SB. Pediatric emergency research Canada: Origins and evolution.\u00a0Pediatr\u00a0Emerg\u00a0Care. 2018;34(2):138\u2013144.","DOI":"10.1097\/PEC.0000000000001360"},{"issue":"2","key":"9125_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1742-6723.2006.00823.x","volume":"18","author":"F Babl","year":"2006","unstructured":"Babl F, Borland M, Ngo P, Acworth J, Krieser D, Pandit S, et al. Paediatric research in emergency departments international collaborative (PREDICT): first steps towards the development of an Australian and New Zealand research network. Emerg Med Australas. 2006;18(2):143\u20137.","journal-title":"Emerg Med Australas"},{"issue":"6","key":"9125_CR13","doi-asserted-by":"publisher","first-page":"e029024","DOI":"10.1136\/bmjopen-2019-029024","volume":"9","author":"L Kelly","year":"2019","unstructured":"Kelly L, Richer L, Ali S, Plint A, Poonai N, Freedman S, et al. Innovative approaches to investigator-initiated, multicentre paediatric clinical trials in Canada. BMJ Open. 2019;9(6):e029024.","journal-title":"BMJ Open"},{"issue":"2","key":"9125_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"P Harris","year":"2009","unstructured":"Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"9125_CR15","unstructured":"WCHRI. Women and Children's Health Research Institute, (WCHRI). Data Coordinating Centre.\u00a0https:\/\/www.wchri.org\/data-coordinating-centre. 2008. Accessed 7\u00a0Aug 2018."},{"issue":"2","key":"9125_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1214\/08-BA310","volume":"3","author":"L Joseph","year":"2008","unstructured":"Joseph L, M\u2019Lan C, Wolfson D. Bayesian sample size determination for binomial proportions. Bayesian Anal. 2008;3(2):269\u201396.","journal-title":"Bayesian Anal"},{"key":"9125_CR17","doi-asserted-by":"crossref","unstructured":"Lan J, Plint AC, Dalziel SR, Klassen TP, Offringa M, Heath A. Remote expert elicitation to determine the prior probability distribution for Bayesian sample size determination in international randomized controlled trials: Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone (BIPED) Study. Clinical Trials, Under Review. 2021.","DOI":"10.21203\/rs.3.rs-952484\/v1"},{"key":"9125_CR18","volume-title":"R: a language and environment for statistical computing.","author":"R Core Team","year":"2018","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2018."},{"key":"9125_CR19","unstructured":"Plummer M. JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling. Proceedings of the 3rd international workshop on distributed statistical computing. 2003;124,125(10):1\u201310."},{"key":"9125_CR20","unstructured":"Stan Development Team. Stan Modeling Language Users Guide and Reference Manual, Version 2.27. https:\/\/mc-stan.org. 2019. Accessed 19 Aug 2021."},{"key":"9125_CR21","doi-asserted-by":"publisher","DOI":"10.1201\/9781315175584","volume-title":"Bayesian inference with INLA","author":"V G\u00f3mez-Rubio","year":"2020","unstructured":"G\u00f3mez-Rubio V. Bayesian inference with INLA. Boca Raton, FL: CRC Press; 2020."},{"issue":"8","key":"9125_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","volume":"276","author":"C Begg","year":"1996","unstructured":"Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 1996;276(8):637\u20139.","journal-title":"JAMA"},{"key":"9125_CR23","doi-asserted-by":"crossref","unstructured":"Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics. 1987;79(6):939\u201345.","DOI":"10.1542\/peds.79.6.939"},{"issue":"3","key":"9125_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1214\/06-BA117A","volume":"1","author":"A Gelman","year":"2006","unstructured":"Gelman A. Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper). Bayesian Anal. 2006;1(3):515\u201334.","journal-title":"Bayesian Anal"},{"issue":"4","key":"9125_CR25","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1214\/08-AOAS191","volume":"2","author":"A Gelman","year":"2008","unstructured":"Gelman A, Jakulin A, Pittau M, Su Y. A weakly informative default prior distribution for logistic and other regression models. Ann Appl Stat. 2008;2(4):1360\u201383.","journal-title":"Ann Appl Stat"},{"key":"9125_CR26","unstructured":"Yang R, Berger JO. A catalog of noninformative priors. Institute of Statistics and Decision Sciences, Durham, NC. 1996;97\u201342."},{"issue":"2","key":"9125_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"E Brown","year":"1999","unstructured":"Brown E, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20(2):109\u201317.","journal-title":"Drug Saf"},{"issue":"2","key":"9125_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1467-9868.2008.00700.x","volume":"71","author":"H Rue","year":"2009","unstructured":"Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. Journal of the royal statistical society: Series b (statistical methodology). 2009;71(2):319\u201392.","journal-title":"Journal of the royal statistical society: Series b (statistical methodology)"},{"issue":"no. 3","key":"9125_CR29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1467-9469.2010.00715.x","volume":"38","author":"S Martino","year":"2011","unstructured":"Martino S, Akerkar R, Rue H. Approximate Bayesian inference for survival models. Scand J Stat. 2011;38(3):514\u201328.","journal-title":"Scand J Stat"},{"issue":"1","key":"9125_CR30","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-3668","volume":"172","author":"D Kent","year":"2020","unstructured":"Kent D, van Klaveren D, Paulus J, D\u2019Agostino R, Goodman S, Hayward R, et al. The predictive approaches to treatment effect heterogeneity (PATH) statement: explanation and elaboration. Ann Intern Med. 2020;172(1):W1\u201325.","journal-title":"Ann Intern Med"},{"issue":"1","key":"9125_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7326\/M18-3667","volume":"172","author":"D Kent","year":"2020","unstructured":"Kent D, van Klaveren D, Paulus J, D\u2019Agostino R, Goodman S, Hayward R, et al. The predictive approaches to treatment effect heterogeneity (PATH) statement. Anna Intern Med. 2020;172(1):35\u201345.","journal-title":"Anna Intern Med"},{"issue":"8","key":"9125_CR32","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/thoraxjnl-2016-208535","volume":"71","author":"O Dumas","year":"2016","unstructured":"Dumas O, Mansbach J, Jartti T, Hasegawa K, Sullivan A, Piedra P, et al. A clustering approach to identify severe bronchiolitis profiles in children. Thorax. 2016;71(8):712\u20138.","journal-title":"Thorax"},{"key":"9125_CR33","first-page":"53","volume":"34","author":"C Rodr\u00edguez-Mart\u00ednez","year":"2020","unstructured":"Rodr\u00edguez-Mart\u00ednez C, Castro-Rodriguez J, Nino G, Midulla F. The impact of viral bronchiolitis phenotyping: is it time to consider phenotype-specific responses to individualize pharmacological management? Paediatr Respir Rev. 2020;34:53\u20138.","journal-title":"Paediatr Respir Rev"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09125-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:52:02Z","timestamp":1762959122000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09125-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9125"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09125-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"REB approval has been obtained for all study sites.\u00a0In Canada, approval has been obtained from Sainte-Justine\u2019s UHC Research Ethics Committee (Study ID 2019-2062), the Children\u2019s Hospital of Eastern Ontario REB (CHEO REB protocol 18\/07 CTO and Lawson Approval R-18-669), the University of Manitoba Biomedical Research Board (HS22184[B2018:09]), the Health REB\u2013Biomedical Panel (Edmonton) (study ID Pro00083863), and the Conjoint Health REB, University of Calgary (Ethics ID REB18-0424). In New Zealand, approval has been granted by the Health and Disability Ethics Committee (Ethics ID 19\/STH\/210). In Australia, approval has been granted by the Child and Adolescent Health Services Human Research Ethics Committee (RGS3033). Consent for enrolment will be obtained from the legal guardians of eligible infants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"496"}}